Biomerica (BMRA) Stock Price
Biomerica Price
Revenue at Biomerica has contracted by 1.3% per year over the past 19 years to 4.45 M USD. Earnings per share have grown at 0.1% per year over the last 6 years. For Biomerica, the net margin of -84.8% is down versus -24.0% a few years ago.
Biomerica stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Biomerica business model & stock analysis
Frequently asked questions about Biomerica
7 analysts currently rate the Biomerica stock: 6 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Biomerica share trades at 1.67 EUR (1.88 USD).
The Biomerica share (BMRA) is listed on 1 stock exchanges, including: NASDAQ (BMRA).
The revenue of Biomerica is 4.45 M USD. This figure is based on current financial data and reflects the company's business performance.
The profit of Biomerica is -3.78 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Biomerica is currently -1.53. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Biomerica stock.
The price-to-sales ratio (P/S) of Biomerica is currently 1.29. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Biomerica stock.
The Eulerpool Quality Score for Biomerica is 2/10.
The ISIN of Biomerica is US09061H4065. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Biomerica is 866251. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Biomerica is BMRA. The ticker symbol is used to trade Biomerica shares on the stock exchange.
Biomerica stock
Biomerica Peer Group
Biomerica Ticker
All fundamentals and in-depth analysis of Biomerica
Our stock analysis for Biomerica stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biomerica. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.